Please note

  • The Institute of Clinical Molecular Biology and Tumor Genetics (KMOLBI) has been closed at the end of December 2015.

    The working groups / departments of the Institute are currently being restructured. A new website is in preparation.

About KMOLBI

  • The main research focus of the Institute of Clinical Molecular Biology and Tumor Genetics are signaling pathways for proliferation, survival, and function of hematopoietic cells. Disruption of these pathways by genetic alterations causes genetic and epigenetic instability and malignant transformation. More...

Research Unit Molecular Epigenetics